about
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsIgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis.Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease.Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic areaRapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementationA Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis.IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions.Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis.Rapid drug susceptibility test of Mycobacterium tuberculosis using microscopic time-lapse imaging in an agarose matrix.Molecular diagnostic methods for the detection of Mycobacterium tuberculosis resistance: the potential of high-resolution melting analysis.Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
P2860
Q24200879-58C2E3F0-554A-44B6-BA23-4C376F8B92C8Q33806944-888963BD-9AB3-48F0-8D10-8BEEE2F53CD3Q33905078-E6DE6744-6849-486C-A715-3B2CC329B3A5Q34133162-A284CE15-ED61-491B-B9D8-141D4376E1DBQ34302593-2519135B-4F02-4415-B854-C5C7B4B5961AQ34976354-2AE47162-0B2D-4977-9129-DBD7D7E64F36Q36038593-89A8BE1C-674A-4687-B676-D0E01BB131EEQ37353352-782995E0-F32E-44E3-9C22-22C06D840637Q37988577-CA03A6D3-5E7F-40DF-96F0-9CD3270BE586Q38854712-769523AD-6535-4326-8D53-FDBAA64168A9Q41920092-FDCACD10-A145-425A-9981-B14AB282C7E5Q49513549-4AAFE55D-18BA-4D35-8FD8-F153825DD8BDQ51472055-28F90C40-598C-4AD5-81A9-8AF3330902F0Q54281247-E58EFEC8-88C1-44B8-B8C9-F7D2DE4F49A4Q55439108-9ADFD211-EDC4-4065-950D-6F27D82B8438Q56964964-EC7DEF5F-6C7E-4FA8-82B0-3A9DCA449397
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tuberculosis assays: past, present and future.
@en
Tuberculosis assays: past, present and future.
@nl
type
label
Tuberculosis assays: past, present and future.
@en
Tuberculosis assays: past, present and future.
@nl
prefLabel
Tuberculosis assays: past, present and future.
@en
Tuberculosis assays: past, present and future.
@nl
P2860
P50
P356
P1476
Tuberculosis assays: past, present and future
@en
P2093
Magdalena Kriel
Thomas C Victor
P2860
P304
P356
10.1586/ERI.11.23
P577
2011-04-01T00:00:00Z